Example: Heart Attack

Search clinical trials for: Mycophenolate Mofetil (MMF)

Total 65 results

NCT05027945

Recruiting

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Conditions: Immunodeficiency, Hematopoietic Stem Cell Transplantation
NCT01861106

Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

Conditions: GATA2, Immunodeficiency, MDS
NCT02918292

Completed

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Conditions: Severe Aplastic Anemia
NCT04339777

Suspended

Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases

Conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases, Common Variable Immunodeficiency, Primary T-cell Immunodeficiency Disorders
NCT03112603

Active, not recruiting

A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Conditions: Graft-versus-host Disease (GVHD)
NCT04660539

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT04311632

Recruiting

A Dose Escalation Study in de Novo Renal Transplantation

Conditions: Kidney Transplantation
NCT02921789

Completed

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Conditions: Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS)
NCT04773392

Recruiting

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Conditions: Kidney Transplantation, Kidney Transplant Rejection
NCT03221257

Active, not recruiting

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

Conditions: Scleroderma, Systemic, Interstitial Lung Disease
NCT05293509

Not yet recruiting

Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

Conditions: Stem Cell Transplantation
NCT01850108

Active, not recruiting

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Conditions: Sickle Cell Disease, Hemoglobinopathies
NCT03842696

Recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Conditions: Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-disease
NCT02217410

Completed

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Conditions: Kidney Transplantation
NCT03018223

Completed

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Conditions: Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia, Primary Myelofibrosis, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Hodgkin Lymphoma, Multiple Myeloma
NCT03674411

Active, not recruiting

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

Conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Relapsed Large Cell Lymphoma, Mantle Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Lymphoplasmacytic Lymphoma
NCT00185640

Completed

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Conditions: Blood Cancer, Leukemia
NCT02137239

Completed

Regimen Optimization Study

Conditions: Kidney Transplantation
NCT03734601

Completed

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorder, Chronic Lymphocytic Leukemia, B-cell Lymphoma, T-cell Lymphoma, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Myelomonocytic Leukemia
NCT04744623

Active, not recruiting

Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone

Conditions: Benign Mucous Membrane Pemphigoid
NCT02540395

Completed

Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation

Conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy
NCT00506948

Terminated

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Conditions: Hematological Malignancies, Myelodysplastic Syndrome, Leukemia, Lymphoma
NCT02532777

Recruiting

The Research of Standard Diagnosis and Treatment for HSPN in Children

Conditions: Henoch-Schoenlein Purpura Nephritis
NCT02936505

Active, not recruiting

Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.

Conditions: Lung Transplantation, Allografts
NCT00657059

Completed

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

Conditions: IgA Nephropathy

Search clinical trials for: Mycophenolate Mofetil (MMF)

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations